Loading insider details...
Latest Form 4 (Nov 20, 2024): Sale of 46,657 SYRS shares, $10.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 20, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Sale | 46,657 | $10.3K |
| Oct 2, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 10,000 | n/a |
| Apr 2, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 22,500 | n/a |
| Oct 20, 2023 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 22,500 | n/a |
| Sep 14, 2023 | Syros Pharmaceuticals, Inc. (SYRS) | Grant/Award | 30,000 | n/a |
| Oct 13, 2022 | Syros Pharmaceuticals, Inc. (SYRS) | Grant/Award | 45,000 | n/a |
| Feb 19, 2021 | Syros Pharmaceuticals, Inc. (SYRS) | Grant/Award | 94,000 | n/a |
| Feb 14, 2020 | Syros Pharmaceuticals, Inc. (SYRS) | Grant/Award | 94,000 | n/a |